IGM Biosciences
IGMS
IGMS was delisted on the 13th of August, 2025.
0 hedge funds and large institutions have $0 invested in IGM Biosciences in 2025 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $508 → $0 (-$508)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
-$508 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Osaic Holdings
Scottsdale,
Arizona
| – | -$508 | -400 | Closed |
|
IGMS Hedge Fund Activity: Q4 2025 in Review
0 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in IGM Biosciences (IGMS) for Q4 2025, worth a combined $0 — down 100% from $508 a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of IGMS and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Osaic Holdings, exiting entirely with an estimated $508 sold.
- 0 institutional investors held IGM Biosciences (IGMS) as of Q4 2025, down from 1 in Q3 2025.
- Funds reported $0 of IGM Biosciences stock for Q4 2025, down 100% quarter-over-quarter.
- 0 funds opened new IGM Biosciences positions in Q4 2025 and 1 closed out, a net change of -1 holder.
- The largest IGM Biosciences seller in Q4 2025 was Osaic Holdings, an estimated $508 sold.
Based on aggregated 13F filings for Q4 2025.